Abstract: Journal of Infectious Diseases and Viruses Research

Abstract:
Blood transfusion is associated with many hazards, especially the exposition to blood transfusion-transmitted bloodborne infectious diseases considered one of the main causes of conflict worldwide, including hepatitis B (HBV) and C virus (HCV) and human immunodeficiency virus (HIV). In great countries blood-borne - pathogens are treated by human public health, so continuous monitoring of blood transfusions must be done to prevent transmitting diseases from healthy donors. All central blood labs led by WHO that licensed Elisa is one of the virological tools, which gives accurate results and has higher sensitivity and specificity compared with other diagnostic tools such as Rapid test immune chromatography (ICT) and radioimmunoassay (RIAs). In this present study, about 8000 samples were diagnosed in the blood central lab between 1/7/2023 -and 31/10/2023 by using the Elisa technique. Out of 8000 blood samples tested for viral infection, HBV, HCV, and HIV were detected in 442, 17, and 12 samples, respectively